Nano-X Imaging (NNOX) Non-Current Deferred Tax Liability (2021 - 2026)
Nano-X Imaging (NNOX) posted quarterly Non-Current Deferred Tax Liability of $505000.0 for Q1 2026, down 79.65% year-on-year from $2.5 million in Q1 2025, and down 15.83% on a QoQ basis from $600000.0 in Q4 2025.
Nano-X Imaging (NNOX) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Non-Current Deferred Tax Liability for 6 consecutive years, with $505000.0 the latest figure, recorded in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability fell 79.65% year-over-year to $505000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $505000.0 (down 79.65% YoY) and the FY2025 annual result came in at $600000.0, down 76.71% from the prior year.
- Non-Current Deferred Tax Liability retreated to $505000.0 in Q1 2026 per NNOX's latest filing, from $600000.0 in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for NNOX reached as high as $6.9 billion in Q1 2022 and fell as low as $505000.0 in Q1 2026.
- A 5-year average of $942.6 million and a median of $2.9 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- The largest YoY upside for Non-Current Deferred Tax Liability was 11.32% in 2023 against a maximum downside of 99.95% in 2023.
- Year by year, Non-Current Deferred Tax Liability stood at $3.3 million in 2022, then slipped by 11.32% to $3.0 million in 2023, then declined by 12.77% to $2.6 million in 2024, then tumbled by 76.71% to $600000.0 in 2025, then declined by 15.83% to $505000.0 in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $505000.0, $600000.0, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nano-X Imaging | 67.53 Mn | 23.68 Mn | -2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 505,000.00 |
| Mar 31, 2026 | 505,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 2.29 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.39 Mn |
| Jun 30, 2025 | 2.39 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 2.86 Mn |
| Mar 31, 2024 | 2.86 Mn |
| Dec 31, 2023 | 2.95 Mn |
| Dec 31, 2023 | 2.95 Mn |